Catalyst Wire Dossier Catalyst Wire Dossier

Ropristine N01

Ropristine N01
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ropristine N01, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP [Phase 2]

See pricing